11 June 2019: The global Histology And Cytology Market is expected to reach USD 26.9 Billion by 2025. Histology is the study of normal cells and tissue conducted using a microscope. Histologists possess some special skills that are necessary for processing and staining tissue samples. In short, histologists and histopathologists are two different terms with different roles to perform.
Cytology specimens are obtained with an objective to scrutinize tissue at a cellular level. The tissues are samples of tissue fragments or free cells. Fine needle aspiration (FNA) is the most common sample type wherein a very thin needle and a syringe are used to obtain small amounts of fluid from a wound.
From the commercial perspective, histology and cytology is used in the diagnostic and research procedure. The market trends are determined along with manufacturer’s preference for development of kits and reagents for several clinical applications. Product segment for histology and cytology industry includes kits and reagents, enzymes, stains and dyes. Kits accounted for a significant CAGR in the forecast period due to preferred diagnostic measure for cytology. Type segment for histology and cytology market includes cervical cancer, breast cancer and cytology.
Application segment for histology & cytology industry includes cell signalling, clinical diagnosis, epigenetics and sequencing studies and molecular diagnostic studies. Molecular diagnostic studies accounted for a significant market share in the past and continues to grow in the forecast period due to increase in ongoing R&D activities.
End-user segment for histology & cytology market includes academic research institutes, diagnostic centers, hospital and biotechnology & pharmaceutical industry. Diagnostic centers accounted for a higher growth in the past due to rise in number. The segment is projected to continue growing at a higher pace due to increase in number of diagnostic tests and rise in patient pool.
https://www.millioninsights.com/industry-reports/histology-cytology-market
Geographical segmentation for histology and cytology industry includes North America, Latin America, Europe, Asia-Pacific, Middle East and Africa. North America accounts for a dominant position in the global market due to improved healthcare infrastructure, rise in cancer incidences and increase in government spending. Asia-Pacific’s market witnesses a higher growth in the forecast period due to economic development and rise in number of multi-specialty hospitals. Rise in foreign investments is another factor responsible for the market growth during the forecast period.
The key players in the histology and cytology market include Abbott Laboratories, Becton, Dickinson and Company, Hologic Inc, Life Technologies Corporation, Thermo Fisher Scientific and Trivitron Healthcare.
No comments:
Post a Comment